Kokorin V.A., Markova O.A., Gordeyev I.G., Boyeva O.I., Fisher V.V., Milto A.S., Mayskov V.V., Pyataev N.A., Minayeva O.V., Stolyarov G.S., Sovershayeva A.L., Papko A.A., Semitko S.P., Shogenov Z.C., Khaisheva L.A., Khorolets E.V., Tankhilevich B.M., Morozova O.V., Pokutnev A.P., Kalugina O.A., Lapin O.M., Popov N.N., Gapchenko E.V., Khamitov P.A., Abbasova S.G., Kazarov A.A., Lykov M.V., Pantyushenko M.S.
Recombinant tissue plazminogen activator Revelisa® in patients with myocardial infarction
|
42-57 |
Scherbak M.M., Shkolnik E.L., Vasyuk Yu.A., Yushchyuk E.N., Trush E.Yu., Burneikaite G., Celutkiene E., Zuoziene G., Petrauskiene B., Laucevicius A.
Global left ventricular myocardial deformation study of extracorporeal cardiac shock wave therapy in stable angina
|
64-70 |